Soligenix (SNGX) Payables (2010 - 2026)
Soligenix's (SNGX) quarterly Payables came in at $828658.0 in Q1 2026, up 38.18% YoY from $599688.0 in Q1 2025, and down 25.71% on a QoQ basis from $1.1 million in Q4 2025.
Soligenix (SNGX) Payables (2010 - 2026) Analysis & Trends
Soligenix (SNGX) has 17 years of Payables data on file, last reported at $828658.0 in Q1 2026.
- Quarterly Payables rose 38.18% year-over-year to $828658.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $828658.0 (up 38.18% YoY) and the FY2025 annual result came in at $1.1 million, up 67.02% from the prior year.
- Payables slipped to $828658.0 in Q1 2026, from $1.1 million in the prior quarter.
- In the past five years, Payables ranged from a high of $4.5 million in Q1 2022 to a low of $599688.0 in Q1 2025.
- A 5-year average of $2.0 million and a median of $1.4 million in 2024 frame the typical range for Payables.
- The widest YoY moves for Payables: up 600.91% in 2022, down 100.0% in 2022.
- Tracing SNGX's Payables over 5 years: stood at $3.9 million in 2022, then plunged by 71.25% to $1.1 million in 2023, then tumbled by 39.9% to $667896.0 in 2024, then jumped by 67.02% to $1.1 million in 2025, then slipped by 25.71% to $828658.0 in 2026.
- The last three Payables figures came in at $828658.0 (Q1 2026), $1.1 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Soligenix | 6.45 Mn | 6.45 Mn | - | 1.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.41 Mn |
| Mar 31, 2026 | 828,658.00 |
| Dec 31, 2025 | 1.12 Mn |
| Sep 30, 2025 | 1.21 Mn |
| Jun 30, 2025 | 649,955.00 |
| Mar 31, 2025 | 599,688.00 |
| Dec 31, 2024 | 667,896.00 |
| Sep 30, 2024 | 891,227.00 |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | 1.44 Mn |
| Dec 31, 2023 | 1.11 Mn |
| Sep 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 2.47 Mn |
| Mar 31, 2023 | 2.77 Mn |
| Dec 31, 2022 | 3.87 Mn |
| Sep 30, 2022 | 4.16 Mn |
| Jun 30, 2022 | 4.14 Mn |
| Mar 31, 2022 | 4.52 Mn |
| Dec 31, 2021 | 2.93 Mn |
| Sep 30, 2021 | 250.00 Bn |